Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a …
Background Multiple studies have provided evidence of suboptimal or poor immune
responses to SARS-CoV-2 vaccines in recipients of hematopoietic stem cell transplantation …
responses to SARS-CoV-2 vaccines in recipients of hematopoietic stem cell transplantation …
Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized …
Background/Purpose Optimizing vaccine efficacy is of particular concern in patients
undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an …
undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an …
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study
Background The optimal timing of vaccination with SARS-CoV-2 vaccines after cellular
therapy is incompletely understood. The objectives of this study are to determine whether …
therapy is incompletely understood. The objectives of this study are to determine whether …
[HTML][HTML] Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized …
Methods In a randomized clinical trial, patients who had already received two primary doses
of receptor-binding domain (RBD) tetanus toxoid (TT) conjugated SARS-CoV-2 vaccine …
of receptor-binding domain (RBD) tetanus toxoid (TT) conjugated SARS-CoV-2 vaccine …
Pre-graft vaccination or infection do not decrease COVID-19 infections in recipients of allogeneic stem cell transplantation vaccinated and/or protected by …
V Letailleur, A Le Bourgeois, T Guillaume… - Human Vaccines & …, 2024 - Taylor & Francis
The impact of pre-graft COVID-19 vaccinations in donor or recipient as well as pre-graft
infection has been studied in 157 adults having received allogeneic stem cell …
infection has been studied in 157 adults having received allogeneic stem cell …
[PDF][PDF] Leyla Sharifi Aliabadi1, Manoochehr Karami1, 2, Maryam Barkhordar3, Seyed Saeed Hashemi Nazari1, Amir Kavousi1, Mohammad Ahmadvand3 and …
M Ahmadvand, M Vaezi, H Nazari, A Kavousi - 2023 - scienceopen.com
Background/Purpose: Optimizing vaccine efficacy is of particular concern in patients
undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an …
undergoing hematopoietic stem cell transplantation (HSCT), which mainly have an …